All hospitals may request a backup controller with modified software for the Heartware Ventricular Assist Device System to use in certain circumstances if the primary controller fails to restart the pump, the Food and Drug Administration announced today. Medtronic last year recalled over 1,600 of the devices because the internal pump may stop and fail to restart, among other safety concerns, but said the risk of removing an implanted device may outweigh the benefits.

Related News Articles

Headline
The Food and Drug Administration announced Dec. 5 that it will launch the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or…
Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group Nov. 18 released a best practices guide for health care organizations and medical device…
Headline
Despite elegant efforts to design for safe use, rigorous standards and regulatory requirements, and lots of training of health care professionals, there’s…
Headline
The Trump administration yesterday announced it issued executive orders authorizing 25% tariffs on all steel and aluminum imports. Importantly, both steel and…
Headline
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such as continuous glucose monitors,…
Headline
The Department of Health and Human Services Sept. 30 released a statement on the dockworker strike at ports along the East and Gulf coasts, saying that…